Contact dermatitis: Allergic and irritant

Clinics in Dermatology

Volumn 32, Issue 1, 2014, Pages 116-124

  Tan, Cher Han ^a   Rasool, Sarah ^a   Johnston, Graham A ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 4 ISOTHIAZOLIN 3 ONE; 5 CHLORO 2 METHYL 4 ISOTHIAZOLIN 3 ONE; ALLERGEN; CHLOROTHALONIL; CORTICOSTEROID; COSMETIC; DETERGENT; EMOLLIENT AGENT; EYE DROPS; FRAGRANCE; HAIR DYE; IODOPROPYNYL BUTYLCARBAMATE; IRRITANT AGENT; MALEIC ACID DIOCTYL ESTER; NEOMYCIN; PIMECROLIMUS; PROPOLIS; SHAMPOO; SODIUM METABISULFITE; SUNSCREEN; TACROLIMUS; UNCLASSIFIED DRUG;

AIRBORNE PARTICLE; ALTERNATIVE MEDICINE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTACT DERMATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; HUMAN; IRRITANT DERMATITIS; MEDICAL RECORD; NOTE; PATHOPHYSIOLOGY; PATIENT COUNSELING; PRIORITY JOURNAL; RISK FACTOR; SKIN ALLERGY; SKIN IRRITATION;

COSMETICS; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, IRRITANT; DETERGENTS; FACIAL DERMATOSES; HUMANS; OPHTHALMIC SOLUTIONS;

EID: 84889576942     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2013.05.033     Document Type: Note

References (94)

1. Thyssen J.P., Linneberg A., Engkilde K., Menne T., Johansen J.D. Contact sensitization to common haptens is associated with atopic dermatitis: new insight. Br J Dermatol 2012, 166:1255-1261.
2. Davies R.F., Johnston G.A. New and emerging cosmetic allergens. Clin Dermatol 2011, 29:311-315.
3. Alexandroff A.B., Johnston G.A. Medical management of contact dermatitis. G Ital Dermatol Venereol 2009, 144:537-540.
4. Non eczematous contact dermatitis. Fisher's Contact Dermatitis 2001, 75-76. Lippincott Williams & Wilkins, Philadelphia. 5th ed. R.L. Rietschel, J.F. Fowler (Eds.).
5. Kohl L., Blondeel A., Song M. Allergic contact dermatitis from cosmetics. Retrospective analysis of 819 patch-tested patients. Dermatology 2002, 204:334-337.
6. Johnston G.A. Occupational dermatology: an evidence-based discipline?. Clin Exp Dermatol 2011, 36:117-118.
7. Huygens S., Goossens A. An update on airborne contact dermatitis. Contact Dermatitis 2001, 44:1-6.
8. Shavit I., Hoffmann Y., Shachor-Meyouhas Y., Knaani-Levinz H. Am J Emerg Med 2008, 26:515.e3-515.e4.
9. Nakayama H., Matsuo S., Hayakawa K., et al. Pigmented cosmetic dermatitis. Int J Dermatol 1984, 23:299-305.
10. Slodownik D., Lee A., Nixon R. Irritant contact dermatitis: a review. Australas J Dermatol 2008, 49:1-9.
11. Marks J.G, Elsner P., Deleo V. Allergic and irritant contact dermatitis. Contact and Occupational Dermatology 2002, 3-12. Mosby, St. Louis, MO. J.G. Marks, P. Elsner, V. Deleo (Eds.).
12. Thyssen J.P., Johansen J.D., Linneberg A., Menne T. The epidemiology of hand eczema in the general population-prevalence and main findings. Contact Dermatitis 2010, 62:75-87.
13. Clark S.C., Zirwas M.J. Management of occupational dermatitis. Dermatol Clin 2009, 27:365-383.
14. Wigger-Alberti W., Elsner P. Contact dermatitis due to irritation. Handbook of Occupational Dermatology 2000, 99-110. Springer-Verlag, New York. L. Kanerva, P. Elsner, J.E. Wahlberg, H.I. Maibach (Eds.).
15. Smith H.R., Basketter D.A., McFadden J.P. Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin Exp Dermatol 2002, 27:138-146.
16. Weltfriend S., Ramon M., Maibach H.I. Irritant dermatitis (irritation). Dermatotoxicology 2004, 181-228. CRC Press, Boca Raton, FL. H. Zhai, H.I. Maibach (Eds.).
17. Fluhr J.W., Darlenski R., Angelova-Fischer I., Tsankov N., Basketter D. Skin irritation and sensitization: mechanisms and new approaches for risk assessment. 1. Skin irritation. Skin Pharmacol Physiol 2008, 21:124-135.
18. Spiekstra S.W., Toebak M.J., Sampat-Sardjoepersad S., et al. Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure. Exp Dermatol 2005, 14:109-116.
19. Wood L.C., Elias P.M., Calhoun C., et al. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 1996, 106:397-403.
20. Wilmer J.L., Burleson F.G., Kayama F., Kanno J., Luster M.I. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J Invest Dermatol 1994, 102:915-922.
21. Eberhard Y., Ortiz S., Ruiz Lascano A., Kuznitzky R., Serra H.M. Up-regulation of the chemokine CCL21 in the skin of subjects exposed to irritants. BMC Immunol 2004, 5:7.
22. De Jongh C.M., Verberk M.M., Withagen C.E., et al. Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermatitis 2006, 54:325-333.
23. Watkins S.A., Maibach H.I. The hardening phenomenon in irritant contact dermatitis: an interpretative update. Contact Dermatitis 2009, 60:123-130.
24. Heinemann C., Paschold C., Fluhr J., et al. Induction of a hardening phenomenon by repeated application of SLS: analysis of lipid changes in the stratum corneum. Acta Derm Venereol 2005, 85:290-295.
25. Schwindt D.A., Wilhelm K.P., Miller D.L., Maibach H.I. Cumulative irritation in older and younger skin: a comparison. Acta Derm Venereol 1998, 78:279-283.
26. Rougier A., Dupuis D., Lotte C., et al. Regional variation in percutaneous absorption in man: measurement by the stripping method. Arch Dermatol Res 1986, 278:465-469.
27. Jakasa I., Verberk M.M., Esposito M., Bos J.D., Kezic S. Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol 2007, 127:129-134.
28. Jakasa I., de Jongh C.M., Verberk M.M., Bos J.D., Kezic S. Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol 2006, 155:104-109.
29. Lerbaek A., Kyvik K.O., Mortensen J., et al. Heritability of hand eczema is not explained by comorbidity with atopic dermatitis. J Invest Dermatol 2007, 127:1632-1640.
30. Zhai H., Maibach H.I. Skin occlusion and irritant and allergic contact dermatitis: an overview. Contact Dermatitis 2001, 44:201-206.
31. John S.M., Uter W. Meteorological influence on NaOH irritation varies with body site. Arch Dermatol Res 2005, 296:320-326.
32. Uter W., Gefeller O., Schwanitz H.J. An epidemiological study of the influence of season (cold and dry air) on the occurrence of irritant skin changes of the hands. Br J Dermatol 1998, 138:266-272.
33. Fluhr J.W., Akengin A., Bornkessel A., et al. Additive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo. Br J Dermatol 2005, 153:125-131.
34. Draelos Z.K. Eye cosmetics. Dermatol Clin 1991, 9:1-7.
35. Loden M., Wessman C. Mascaras may cause irritant contact dermatitis. Int J Cosmet Sci 2002, 24:281-285.
36. Lodde B., Paul M., Roguedas-Contios A.M., et al. Occupational dermatitis in workers exposed to detergents, disinfectants, and antiseptics. Skinmed 2012, 10:144-150.
37. Oiso N., Fukai K., Ishii M. Irritant contact dermatitis from benzalkonium chloride in shampoo. Contact Dermatitis 2005, 52:54.
38. Lensen G., Jungbauer F., Goncalo M., Coenraads P.J. Airborne irritant contact dermatitis and conjunctivitis after occupational exposure to chlorothalonil in textiles. Contact Dermatitis 2007, 57:181-186.
39. Modi G.M., Doherty C.B., Katta R., Orengo I.F. Irritant contact dermatitis from plants. Dermatitis 2009, 20:63-78.
40. Bordel-Gomez M.T., Miranda-Romero A. Fibreglass dermatitis: a report of 2 cases. Contact Dermatitis 2008, 59:120-122.
41. Morris-Jones R., Robertson S.J., Ross J.S., et al. Dermatitis caused by physical irritants. Br J Dermatol 2002, 147:270-275.
42. Kokelj F., Plozzer C. Irritant contact dermatitis from the jellyfish Rhizostoma pulmo. Contact Dermatitis 2002, 46:179-180.
43. Nicolaou N., Johnston G.A. The use of complementary medicine by patients referred to a contact dermatitis clinic. Contact Dermatitis 2004, 51:30-33.
44. Saint-Mezard P., Krasteva M., Chavagnac C., et al. Afferent and efferent phases of allergic Contact Dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD. J Invest Dermatol 2003, 120:641-647.
45. Hanifin J.M. Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. J Invest Dermatol 2009, 129:320-322.
46. O'Regan G.M., Sandilands A., McLean W.H., Irvine A.D. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008, 122:689-693.
47. Mortz C.G., Andersen K.E. New aspects in allergic contact dermatitis. Curr Opin Allergy Clin Immunol 2008, 8:428-432.
48. Warshaw E.M., Buchholz H.J., Belsito D.V., et al. Allergic patch test reactions associated with cosmetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2004. J Am Acad Dermatol 2009, 60:23-38.
49. Kammeyer A., Bos J.D., Teunissen M.B. Postelicitation model of allergic contact dermatitis for predicting the efficacy of topical drugs. Exp Dermatol 2009, 18:44-49.
50. Lundov M.D., Moesby L., Zachariae C., Johansen J.D. Contamination versus preservation of cosmetics: a review on legislation, usage, infections, and contact allergy. Contact Dermatitis 2009, 60:70-78.
51. De Mozzi P., Alexandroff A.B., Johnston G.A. Updates from the British Association of Dermatologists 91st annual meeting, 5-7 July 2011, London, U.K. Br J Dermatol 2012, 167:232-239.
52. Ghazavi M.K., Johnston G.A. An outbreak of occupational allergic contact dermatitis caused by 2-N-octyl-4-isothiazolin-3-one among workers in an adhesive factory. Contact Dermatitis 2011, 64:114-115.
53. Schnuch A., Geier J., Brasch J., Uter W. The preservative iodopropynyl butylcarbamate: frequency of allergic reactions and diagnostic considerations. Contact Dermatitis 2002, 46:153-156.
54. Davis R.F., Johnston G.A. Iodopropynyl butylcarbamate contact allergy from wood preservative. Contact Dermatitis 2007, 56:112.
55. Natkunarajah J., Osborne V., Holden C. Allergic contact dermatitis to iodopropynyl butylcarbamate found in a cosmetic cleansing wipe. Contact Dermatitis 2008, 58:316-317.
56. Bryld L.E., Agner T., Rastogi S.C., Menne T. Iodopropynyl butylcarbamate: a new contact allergen. Contact Dermatitis 1997, 36:156-158.
57. Brasch J., Schnuch A., Geier J., Aberer W., Uter W. German Contact Dermatitis Research Group; Information Network of Departments of Dermatology. Iodopropynylbutyl carbamate 0.2% is suggested for patch testing of patients with eczema possibly related to preservatives. Br J Dermatol 2004, 151:608-615.
58. Madan V., Walker S.L., Beck M.H. Sodium metabisulfite allergy is common but is it relevant?. Contact Dermatitis 2007, 57:173-176.
59. Malik M.M., Hegarty M.A., Bourke J.F. Sodium metabisulfite-a marker for cosmetic allergy?. Contact Dermatitis 2007, 56:241-242.
60. Tucker S.C., Yell J.A., Beck M.H. Allergic contact dermatitis from sodium metabisulfite in Trimovate cream. Contact Dermatitis 1999, 40:164.
61. Gulbahar O., Ozturk G., Erdem N., Kazandi A.C., Kokuludag A. Psoriasiform contact dermatitis due to propolis in a beekeeper. Ann Allergy Asthma Immunol 2005, 94:509-511.
62. Menniti-Ippolito F., Mazzanti G., Vitalone A., Firenzuoli F., Santuccio C. Surveillance of suspected adverse reactions to natural health products: the case of propolis. Drug Saf 2008, 31:419-423.
63. Walgrave S.E., Warshaw E.M., Glesne L.A. Allergic contact dermatitis from propolis. Dermatitis 2005, 16:209-215.
64. Hasan T., Rantanen T., Alanko K., et al. Patch test reactions to cosmetic allergens in 1995-1997 and 2000-2002 in Finland-a multicentre study. Contact Dermatitis 2005, 53:40-45.
65. Lotery H., Kirk S., Beck M., et al. Dicaprylyl maleate-an emerging cosmetic allergen. Contact Dermatitis 2007, 57:169-172.
66. Chan I., Wakelin S.H. Allergic contact dermatitis from dioctyl maleate in a moisturizer. Contact Dermatitis 2006, 55:250.
67. Nilsson J., Carlberg J., Abrahamsson P., et al. Evaluation of ionization techniques for mass spectrometric detection of contact allergenic hydroperoxides formed by autoxidation of fragrance terpenes. Rapid Commun Mass Spectrom 2008, 22:3593-3598.
68. McFadden J.P., Yeo L., White J.L. Clinical and experimental aspects of allergic contact dermatitis to para-phenylenediamine. Clin Dermatol 2011, 29:316-324.
69. Wong T., Orton D. Sunscreen allergy and its investigation. Clin Dermatol 2011, 29:306-310.
70. Bryden A.M., Moseley H., Ibbotson S.H., et al. Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. Br J Dermatol 2006, 155:737-747.
71. Hughes T.M., Stone N.M. Benzophenone 4: an emerging allergen in cosmetics and toiletries?. Contact Dermatitis 2007, 56:153-156.
72. Alanko K., Jolanki R., Estlander T., Kanerva L. Occupational allergic contact dermatitis from benzophenone-4 in hair-care products. Contact Dermatitis 2001, 44:188.
73. Kai A.C., White J.M., White I.R., Johnston G., McFadden J.P. Contact dermatitis caused by C30-38 olefin/isopropyl maleate/MA copolymer in a sunscreen. Contact Dermatitis 2011, 64:353-354.
74. Swinnen I., Goossens A., Rustemeyer T. Allergic contact dermatitis caused by C30-38 olefin/isopropyl maleate/MA copolymer in cosmetics. Contact Dermatitis 2012, 67:318-320.
75. Ghazavi M.K., Johnston G.A. Photo-allergic contact dermatitis caused by isoamyl p-methoxycinnamate in an 'organic' sunscreen. Contact Dermatitis 2011, 64:115-116.
76. Alexandroff A.B., Flohr C., Johnston G.A. Updates from the British Association of Dermatologists 89th Annual Meeting, 7-10 July 2009, Glasgow, U.K. Br J Dermatol 2010, 163:27-37.
77. de Groot A.C., Frosch P.J. Adverse reactions to fragrances. A clinical review. Contact Dermatitis 1997, 36:57-86.
78. Schnuch A., Uter W., Geier J., Gefeller O., IVDK Study Group Epidemiology of contact allergy: an estimation of morbidity employing the clinical epidemiology and drug-utilization research (CE-DUR) approach. Contact Dermatitis 2002, 47:32-39.
79. Rastogi S.C., Menne T., Johansen J.D. The composition of fine fragrances is changing. Contact Dermatitis 2003, 48:130-132.
80. Larsen W.G. Perfume dermatitis. a study of 20 patients. Arch Dermatol 1977, 113:623-626.
81. de Groot A.C., van der Kley A.M., Bruynzeel D.P., et al. Frequency of false-negative reactions to the fragrance mix. Contact Dermatitis 1993, 28:139-140.
82. Frosch P.J., Pirker C., Rastogi S.C., et al. Patch testing with a new fragrance mix detects additional patients sensitive to perfumes and missed by the current fragrance mix. Contact Dermatitis 2005, 52:207-215.
83. Militello G., James W. Lyral: a fragrance allergen. Dermatitis 2005, 16:41-44.
84. Bruze M., Andersen K.E., Goossens A. ESCD; EECDRG. Recommendation to include fragrance mix 2 and hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral) in the European baseline patch test series. Contact Dermatitis 2008, 58:129-133.
85. Belsito D.V., Fowler J.F., Sasseville D., et al. Delayed-type hypersensitivity to fragrance materials in a select North American population. Dermatitis 2006, 17:23-28.
86. Matura M., Skold M., Borje A., et al. Not only oxidized R-(+)- but also S-(-)-limonene is a common cause of contact allergy in dermatitis patients in Europe. Contact Dermatitis 2006, 55:274-279.
87. Karlberg A.T., Magnusson K., Nilsson U. Air oxidation of d-limonene (the citrus solvent) creates potent allergens. Contact Dermatitis 1992, 26:332-340.
88. Karlberg A.T., Dooms-Goossens A. Contact allergy to oxidized d-limonene among dermatitis patients. Contact Dermatitis 1997, 36:201-206.
89. Johansen J.D., Frosch P.J., Svedman C., et al. Hydroxyisohexyl 3-cyclohexene carboxaldehyde- known as Lyral: quantitative aspects and risk assessment of an important fragrance allergen. Contact Dermatitis 2003, 48:310-316.
90. Elberling J., Linneberg A., Mosbech H., et al. A link between skin and airways regarding sensitivity to fragrance products?. Br J Dermatol 2004, 151:1197-1203.
91. Novitskaya E.S., Dean S.J., Craig J.P., Alexandroff A.B. Current dilemmas and controversies in allergic Contact Dermatitis to ophthalmic medications. Clin Dermatol 2011, 29:295-299.
92. Davis R.F., Mortimer N.J., Sladden M.J., Johnston G.A. The use of dietary manipulation in patients referred to a contact dermatitis clinic. Br J Dermatol 2008, 158:639-640.
93. Ashcroft D.M., Dimmock P., Garside R., Stein K., Williams H.C. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005, 330:516.
94. Cohen D.E., Heidary N. Treatment of irritant and allergic contact dermatitis. Dermatol Ther 2004, 17:334-340.